0001192482-13-000239.txt : 20131219 0001192482-13-000239.hdr.sgml : 20131219 20131219124837 ACCESSION NUMBER: 0001192482-13-000239 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131217 FILED AS OF DATE: 20131219 DATE AS OF CHANGE: 20131219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TETRALOGIC PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001361248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 343 PHOENIXVILLE PIKE CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-889-9900 MAIL ADDRESS: STREET 1: 343 PHOENIXVILLE PIKE CITY: MALVERN STATE: PA ZIP: 19355 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gavin Brenda D CENTRAL INDEX KEY: 0001488182 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36208 FILM NUMBER: 131287719 MAIL ADDRESS: STREET 1: C/O QUAKER BIOVENTURES STREET 2: CIRCA CENTRE, 2929 ARCH STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-12-17 0001361248 TETRALOGIC PHARMACEUTICALS CORP TLOG 0001488182 Gavin Brenda D C/O TETRALOGIC PHARMACEUTICALS CORP 343 PHOENIXVILLE PIKE MALVERN PA 19355 1 0 0 0 Common Stock 2013-12-17 4 C 0 48183 7.00 A 948268 I See footnote Convertible Notes 7.00 2013-12-17 4 C 0 48183 D Common Stock 48183 0 I See footnote The Convertible Notes and Accrued Interest automatically converted into Common Stock without payment of further consideration upon the closing of the Issuer's initial public offering, at the initial public offering price of $7.00 per share, which occurred on December 17, 2013. These securities are owned of record by Quaker BioVentures, L.P. Quaker Partners Management L.P. is the general partner of Quaker BioVentures, L.P. The reporting person, a partner of Quaker Partners Management L.P., shares voting and investment power over the shares beneficially owned by Quaker BioVentures, L.P. and Quaker Partners Management L.P., and disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. /s/ Richard L. Sherman, Attorney-In-Fact for Brenda Gavin 2013-12-19